- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NBTX
Recent news which mentions NBTX
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 08, 2022
From Benzinga
From InvestorPlace
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 01, 2022
From Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
July 01, 2022
From Benzinga
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
From InvestorPlace
Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies
April 12, 2022
Tickers
NBTX
From Benzinga
Earnings Scheduled For March 30, 2022
March 30, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
From Benzinga
Is Oncolytics Biotech's GOBLET Study Making Headway in the Fight Against Pancreatic and Colorectal Tumors?
January 25, 2022
From Benzinga
58 Biggest Movers From Yesterday
January 07, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 06, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 08, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 07, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 10, 2021
From Benzinga
Earnings Scheduled For September 8, 2021
September 08, 2021
From Benzinga
Earnings Scheduled For September 3, 2021
September 03, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.